efficacyAgainstSymptomaticCOVID19
P37231
predicate
Indicates the degree to which an intervention reduces the occurrence of symptomatic COVID-19 in a population compared to a control condition.
All labels observed (1)
| Label | Occurrences |
|---|---|
| efficacyAgainstSymptomaticCOVID19 canonical | 2 |
Sample triples (2)
| Subject | Object |
|---|---|
| Janssen COVID-19 Vaccine | approximately 66 percent in global phase 3 trial ⓘ |
| Ad26.COV2.S | approximately 66% in global Phase III trial ⓘ |